| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $590K | — | +809.7% |
| Cost of Revenue | $15K | — | -74.7% |
| Gross Profit | $575K | — | — |
| R&D Expense | $169K | -79.9% | -86.5% |
| SG&A Expense | $2.2M | -26.0% | +1184.0% |
| Operating Income | -$4.4M | +15.4% | -24.7% |
| Pre-tax Income | -$3.6M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $590K | — | +5557.2% |
| Inventory | $235K | — | +2874.6% |
| Current Assets | $1.4M | +65.9% | -80.4% |
| Total Assets | $104.8M | +0.5% | +11.2% |
| Current Liabilities | $7.4M | -4.4% | +35.8% |
| Long-term Debt | $2.0M |
| Line Item | 2025-09-30 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$8.2M | — | — |
| Capital Expenditures | $12K | — | — |
| Investing Cash Flow | $27.6M | — | — |
| Financing Cash Flow | $8.3M | — | — |
| Free Cash Flow | -$8.2M | — | — |
| -13.3% |
| Net Income | -$3.6M | +46.3% | -13.3% |
| EPS (Basic) | -$0.19 | +60.4% | +85.8% |
| EPS (Diluted) | -$0.19 | +60.4% | +85.8% |
| -44.1% |
| — |
| Total Liabilities | $22.2M | -16.2% | +142.8% |
| Stockholders' Equity | $82.7M | +6.2% | -2.9% |